News
ACIR features Immunetune’s presentation at CIMT Annual Meeting 2022
Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune's presentation during the Cancer Immunotherapy (CIMT) Annual Meeting 2022 held May 10-12 in Mainz, Germany. At CIMT, our CSO Jeroen van Bergen presented new preclinical results on our neoantigen...
Immunetune and Daicel Initiate Research Collaboration on Vaccine Injection Device
Immunetune and Daicel Initiate Research Collaboration on Vaccine Injection Device LEIDEN, the Netherlands; OSAKA, Japan; April 22, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases,...
Immunetune Announces Presentations at Industry Conferences during April and May 2022
Immunetune Announces Presentations at Industry Conferences during April and May 2022 LEIDEN, the Netherlands, April 20, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced the...
ACIR features Immunetune’s presentation at CIMT Annual Meeting 2022
Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune's presentation during the Cancer Immunotherapy (CIMT) Annual Meeting 2022 held May 10-12 in Mainz, Germany. At CIMT, our CSO Jeroen van Bergen presented new preclinical results on our neoantigen...
Immunetune and Daicel Initiate Research Collaboration on Vaccine Injection Device
Immunetune and Daicel Initiate Research Collaboration on Vaccine Injection Device LEIDEN, the Netherlands; OSAKA, Japan; April 22, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases,...
Immunetune Announces Presentations at Industry Conferences during April and May 2022
Immunetune Announces Presentations at Industry Conferences during April and May 2022 LEIDEN, the Netherlands, April 20, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced the...
Sachs European Life Sciences CEO Forum
Sachs 15th Annual European Life Science CEO Forum February 28 - March 4, Digital Conference